Vellmet GP 2mg/500mg/15mg Tablet ER
Marketer
Vellinton Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Vellmet GP 2mg/500mg/15mg Tablet ER
Combiflex DM 2mg/500mg/15mg Extended-Release Tablets are a triple-combination medication designed to manage blood glucose levels. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and duration for Combiflex DM 2mg/500mg/15mg ER Tablets. Take it with food to minimize stomach discomfort. If a dose is missed, take it immediately; however, if your next dose is imminent, skip the missed dose and resume your regular schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipping meals increases the risk of hypoglycemia. Regular blood sugar monitoring is crucial during treatment. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any kidney, liver, or heart conditions. Pregnant or lactating individuals should consult their physician before use. Kidney function tests will be conducted by your doctor before initiating therapy. Limit alcohol consumption, as it may elevate the risk of side effects.
Primary Ingredients of Vellmet GP 2mg/500mg/15mg Tablet ER
No information provided. A rewritten text cannot be provided.
Uses of Vellmet GP 2mg/500mg/15mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Vellmet GP 2mg/500mg/15mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. Vellmet GP 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Vellmet GP 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Vellmet GP 2mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vellmet GP 2mg/500mg/15mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Vellmet GP 2mg/500mg/15mg Tablet ER works:
Vellmet GP 2mg/500mg/15mg Extended-Release tablets contain glimepiride, metformin, and pioglitazone, three antidiabetic agents with distinct actions. This triple combination improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone, a thiazolidinedione, further boosts insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Vellmet GP 2mg/500mg/15mg Extended-Release Tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vellmet GP tablets (2mg/500mg/15mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against the risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vellmet GP tablets (2mg/500mg/15mg) are likely not safe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Vellmet GP 2mg/500mg/15mg Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Vellmet GP 2mg/500mg/15mg Tablet ER is contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended throughout the treatment period.
LiverCAUTION
Patients with liver impairment should use Vellmet GP 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Vellmet GP 2mg/500mg/15mg Extended-Release tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Vellmet GP 2mg/500mg/15mg Tablet ER :
Should you forget a dose of Vellmet GP 2mg/500mg/15mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vellmet GP 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently